Search Results 971-980 of 18990 for Neutrophil

1. Clinical trials - Oncology (Medical)

   MC1733, Phase I Trial of Intratumoral Administration of a Measles Virus Derivative Expressing the Helicobacter pylori Neutrophil-activating Protein (NAP) ...

2. Phase 1 Study to Evaluate the Safety of ATA188 in Subjects With Progressive and Relapsing-Remitting Multiple Sclerosis - Mayo Clinic

   Hemoglobin < 10 g/dL; platelet < 100×109/L; absolute neutrophil count < 1.5×109/L. Any contraindication to MRI and/or Gd, eg, any object that is reactive to ...

3. Veliparib and Topotecan Hydrochloride in Treating Patients with Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer - Mayo Clinic

   Absolute neutrophil count ≥ 1500/mcL; Hemoglobin ≥ 9.0 g/dL; Platelets ≥ 100,000/mcL; Total bilirubin ≤ 1.5x the upper limit of normal (ULN); Serum glutamic ...

4. A Study to Evaluate Effectiveness and Safety of TD-1473 in Ulcerative Colitis - Mayo Clinic

   Absolute neutrophil count < 1.5 x 10^9 /L;; Absolute lymphocyte count < 0.8 x 10^9 /L;; Hemoglobin < 8 g/dL; or; Platelet count < 100 x 10^9 /L. Has a ...

5. Intra-patient Dose Escalation Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients with Dumping Syndrome - Mayo Clinic

   Absolute Neutrophil Count (ANC) < 1.5 x 109/L; Platelets < 100 x 109/L; Hb < 9 g/dL; INR ≥ 1.3; Serum creatinine >2.0 mg/dL; Alkaline phosphatase >2.5 x ULN ...

6. Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and Long-Term Rates of Organ Preservation - Mayo Clinic

   - Absolute neutrophil count (ANC) >= 1,500/mm^3 - Platelet count >= 100,000/mm - Creatinine =< 1.5 x upper limit of normal (ULN) OR calculated (calc ...

7. Synergy with Grid Therapy and Immune Checkpoint Inhibitors in Stage IV Non-Small Cell Lung Cancer - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1500/mm^3;; Platelet count ≥ 100,000/mm^3;; Total bilirubin ≤ 1.5 x ULN or direct bilirubin ≤ ULN if total bilirubin is ...

8. Study of Selective BRAF Kinase Inhibitor Dabrafenib Monotherapy Twice Daily and in Combination with Dabrafenib Twice Daily and Trametinib Once Daily in Combination Therapy in Subjects With BRAF V600E Mutation Positive Metastatic (Stage IV) Non-small Cell Lung Cancer - Mayo Clinic

   Absolute neutrophil count (ANC) ≥1.5x109/L; Hemoglobin ≥9 g/dL; Platelets ≥100x109/L; Prothrombin time /International normalized ratio (INR) and partial ...

9. A Study of SC-006 in Subjects With Advanced Cancer - Mayo Clinic

   Absolute neutrophil count (ANC) ≥500/μL;; Platelet count >140,000/μL;; Hemoglobin ≥.0 g/dL;; Serum total bilirubin ≤.5× ULN or ≤× ULN for subjects with ...

10. A Study of AbGn-107 in Patients With Gastric, Colorectal, or Pancreatic Cancer - Mayo Clinic

    Absolute neutrophil count ≥1.5 x 109/L,; Hemoglobin ≥9 g/dL,; Platelet count ≥100 x 109/L,; Serum creatinine ≤1.5 x upper limit of normal (ULN) or a ...